Member Info for Sisyphus

NOT SDS sunrise! I mean SDS the subsidiary of PPR [Pentagon]. They picked up SDS and it looks a blinding little addition. Check the PPR RNS. They rejected an offer from Westminster just before Christmas as 'undervaluing the Co' - you better believe it.

Hope you picked up some of these, I see a rising price espacially as it's gone blue in a sea of red this week. Checked PEG and outlook lokks good hence it's resilience against the fall today. I'd like to see a little less gearing but the price:t/o looks encouraging and the history and business links are strong. Will check next week and pick some up after I've dug deeper. [Check out PPR for the same reasons - good contract contacts and SDS is a real little gem in this uncertain world. It should prove a good hedge against the unknown possibility and raised terrorist risk. A share like this should be an integral part of any portfolio as I have realised before!]

Posted Mon 10% up Friday. That's what I like. And I'm not the only one on the board now! Good share - onward and upward. Handygandhi - you should have grabbed some this morning :-)))

There's nothing that's as much fun as having a board where you can chat to yourself - it's very soporific! Especially when you've researched the share - it's got 250 private shareholders [at the last count] holding shares that have IMHO hit the bottom spot according to my post. Bring it on - Dead board? Just wait boys - this will be buzzing in March and I'll post you back to this and say I told you so! GKP was a dead board once and I was on there but that's another story. Sync's one to come.

Come on - where's your sense of adventure! At this price it's a steal - there's only 250 private shareholders out there :-))

There’s no point in investing in a business that is going backwards. There are plenty of companies out there that are hanging on to their customers, but are threatened by cut priced competition from overseas... by new technologies... or simply because the world is passing it by. There’s no point in investing in a business that is struggling against the tide of progress. This CANNOT be levelled at Vindon. Vindon has seen its revenues increase by an average of 20% per annum over the last four years. That’s why it has built a new headquarters and increased the size of its facilities. It’s responding to the market, and the market wants more of what Vindon has to offer. This is the basis of a successful, expanding, company. However good the business, if we pay too much for our share of it, we will end up losing money. Vindon made a profit, before tax, of £1.5m profit in 2008. If you owned the entire company this profit would be yours. At its current share price of 9.5p, the stock market values Vindon at £8.5m. That means if you bought every share in the company, thereby becoming the sole owner of Vindon, it would cost you £8.5m. The downgrade at present is showing an expectation of £1m profit. So for £8.5m you would get a business that delivered to you a profit of £1m. That would represent a return of 11.75% on your investment – a lot more than you would get putting your £8.5m in the bank. This is a minor hiccup in a growing business that pays a dividend! We can expect Vindon to make an even bigger profit in 2009 – and carry on growing thereafter.

Hear ye! Hear ye! This share is just off the radar and I hate talking to myself. Why invest in Vindon - here goes: Spending on research and development of new drugs grew from $12bn in 1995 to over $35bn in 2006. The world’s pharmaceutical giants are desperate to find new cures. But drugs cannot just be invented and then sold. There’s one intermediate stage, and it is very important... A drug, taken today and in this country might be very effective. But by the time it has been transported to Australia and stored in the hot, dusty atmosphere of Alice Springs it might have lost potency. Before it can be approved for sale, any new drug must be tested under all extremes of temperature and humidity. Glaxo and Pfizer don’t want to be placing parcels of drugs in the heat of the Australian desert, the chill of Iceland or the cloying humidity of Florida... much better to put these compounds “Controlled Storage Rooms”. Vindon Healthcare (VDN) has at its Rochdale headquarters a whole range of Controlled Storage Rooms, in which all combinations of temperature and humidity can be created. Whether it’s the effect of a West Indian sun or an icy Arctic wind – Vindon can recreate it. The pharmas give Vindon samples of their drugs. Vindon subjects them to all manner of atmospheric conditions – and if the drug comes through unaffected, then it can be approved for sale. There’s no way round it. The testing of drugs in this way is essential to a product licence. Vindon Healthcare has spent over £2m on a new, larger, better HQ building in Rochdale. That has cost money, and that money has had to be borrowed from the bank. Because of the nature of Vindon’s business it signs long-term contracts with its customers. Those drugs have to be stored for a long time, and that means future income is guaranteed. Indeed Vindon has said it will receive £4.05m of income in the coming years , just from the business that it already has on its books. So although Vindon has borrowed £2.5m to finance its expansion, Vindon is making enough money to pay all this back within two years, leaving it with all the financial ammunition it needs to expand. Vindon made a profit of £1,500,000 in 2008. Its revenues totalled £5.51m and its costs amounted to £3.94m. And after a small expense for financing and a £440,000 tax charge, £1,060,000 was left. It’s kept most of this money in the business, but it also decided topay a dividend of 0.15p for every share held. This means that for every 1,000 shares that you hold you will receive £15 this year – and probably more next year. It is nice to receive a dividend, and this is an important part of the return from holding shares. But it’s not essential. What really matters is that the company has so much cash in the bank that it can pay a dividend if it wants to. This is the case with Vindon and my two

All time low?? Interests me as I'm in healthcare/pharma. Why? Profits warning sent it south. 89m shares out. Research - Only 250 private shareholders/increased earnings upto hiccup/pays a dividend. Check background and website - looks good. Growing market : new premises and contracts ; UK Ireland States - diversifying strategy. Yep I'm in. Looks onto a good growth plan after this minor hitch. Just bought US distributor with new site by mid 2010.

This is a sitter - do your sums and DYOR. I shall underline my previous post and come back when it has increased. This share ticks all the boxes for short/medium/long term investment and now is the time to go in as you can buy 50000 at 4.28p - way too low. No ramp, just honest to goodness advice to go look at the figures and DYOR.

This is a steal. Check the interims. Strip out the sensible asset write-downs on Zeus etc [but keep the 2009 prospects as data comes through] and the day-to-day business made 1.86 Aust cents ie 0.9p per share in six months and is winning and extending contracts. One signed contract is only recognised in 2nd half so eps should be higher and India and malaysia lokking up. If second half does 0.9 to 1.2p we are looking at a p/e of 2! That's ridiculously low for a business making [rapidly increasing] profits in this business with undervalued assets. The whole picture has been distorted by the asset write-down. This company has cash/is highly cash generative and has good and solid assets. Please DYOR and pick up these whilst they are still excellent value. I don't do ramping, just repay the indepth research that has helped me ake sensible informed decisions in the past.

No posters and yet this is making good sustainable profits - all it did was write down oil assets and they are now in the book for buttons if/when the oil price lifts. Good, well run, yr-on-yr growing profits from its drilling mud. Picked up 50k at 4.28p - it's a no-brainer that this will rise - no ramp needed. I can see x2 to x4 before summers out. DYOR - check the figures and check the earnings - growing and going places. It'lldome just like GKP and TRP.

Take that on board and agree with market reaction being perverse but fundamentals are still pretty sound. The assets are tangible and producing income [however unpredictable at present]. This is surely a case of the predator must become the prey if it shows any weakness...and the shareprice is unfairly weak at present. I'm happy to hold as I think the rewards of holding outweigh the risks, just think an opportunistic bid is imminent and will deny me the bigger spoils of holding - that's life.

Agree - too good a list of assets to wobble around 30p. No comment at present from Augean - take that to mean sensitive bartering on price and - next comes the offer. 70p?? Dunno but either way it's a fair bet that just by making money it will attract attention in current climate. I'll stick with it and see whilst there's action in the other shares I'm holding.

I can't see how the market can pummel AUG....... OK the overall UK outlook is not too rosy, but this has to be one of the few shares that can weather and grow and I'm sure as snows white that a couple of Hazchem guys are running the sliderule over these today. The lack of any comment on offer period makes me think announcement will cme sooner rather than later...all IMHO as usual.

Good results - conservative but sensible forecast. No news on potential offers but these results make me think one will come sooner rather than later. Will contact AUG to find out current sit.

Just a quick note - Check GKP - I'm in today. DYOR on prospects in Middle East [not Algeria] - directors bought. Could open oil sales very soon. Currently at low.

QSP and 02/08/02 - the day it went t*ts up -------------- owwwwwwwwwwwwwwwwwwwwwww! That really really hurt! I'm gone - take me another 7 years to say that again!

I'm off for a beer now with the other half. Just hope news is better with AUG on Tuesday than Man U today - owww! Boyfs of 2 out of 3 daughters support Liverpool - guess who supports MU??? [or stood in the cold for 20 years when he lived in Manchester! I'm getting mugged by text at the moment --- cowards ;-)))

That sounds like stakebuilding for MBO if consistent and also mirrors directors. I'll check out but the only share I ever got really burned on [big-time] was an IT outfit - I'm phobic of any share containing a Q and 020802!!! He said hitting his head against the wall - took me a lot of good deals to recover that mother!!

I did notice Morse as lots of concerted buying by directors from around 7/8p if I remember and they keep buying as price rises. Don't hold big % though do they?